Assembly Biosciences, Inc. Amortization of Debt Issuance Costs and Discounts
Assembly Biosciences, Inc. (ASMB) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2014-05-14
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for the quarter ending 2014-03-31 was $0.00.
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for the quarter ending 2013-09-30 was $0.00.
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for the quarter ending 2013-06-30 was $0.00.
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for the quarter ending 2013-03-31 was $0.00.
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for fiscal 2013 was $0.00.
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for fiscal 2011 was $328.96K, a 85.86% decline from fiscal 2010.
- Assembly Biosciences, Inc. amortization of debt issuance costs and discounts for fiscal 2010 was $2.33M, a 1889.87% increase from fiscal 2009.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month | Amortization of Debt Issuance Costs and Discounts 69 month | Amortization of Debt Issuance Costs and Discounts 72 month | Amortization of Debt Issuance Costs and Discounts 75 month | Amortization of Debt Issuance Costs and Discounts 78 month | Amortization of Debt Issuance Costs and Discounts 81 month | Amortization of Debt Issuance Costs and Discounts 84 month | Amortization of Debt Issuance Costs and Discounts 87 month | Amortization of Debt Issuance Costs and Discounts 90 month | Amortization of Debt Issuance Costs and Discounts 93 month | Amortization of Debt Issuance Costs and Discounts 96 month | Amortization of Debt Issuance Costs and Discounts 99 month | Amortization of Debt Issuance Costs and Discounts 102 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $3.47M 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | $0.00 10-K · filed 2014-03-31 | $3.47M 10-K · filed 2014-03-31 | ||||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 96 month − 10-Q 93 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $3.47M 10-Q · filed 2013-11-12 | |||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 93 month − 10-Q 90 month · filed 2013-08-09 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $3.47M 10-Q · filed 2013-08-09 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $3.47M 10-Q · filed 2013-05-10 | |||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 derived: sum of 2 quarters · filed 2014-03-31 | $0.00 derived: sum of 3 quarters · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | $3.47M 10-K · filed 2013-03-18 | |||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | $0.00 derived: sum of 4 quarters · filed 2013-11-12 | $3.47M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $0.00 derived: sum of 3 quarters · filed 2013-08-09 | $279.93K derived: sum of 4 quarters · filed 2013-08-09 | $3.47M 10-Q · filed 2012-08-09 | |||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-10 | $0.00 derived: sum of 2 quarters · filed 2013-05-10 | $279.93K derived: sum of 3 quarters · filed 2013-05-10 | $3.47M 10-Q · filed 2012-05-09 | ||||||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $279.93K derived: sum of 2 quarters · filed 2013-03-18 | $328.96K 10-K · filed 2013-03-18 | $3.47M 10-K · filed 2012-03-14 | ||||||||||||
| 2011-09-30 | $279.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $328.96K 10-Q · filed 2012-11-13 | $3.47M 10-Q/A · filed 2011-11-18 | |||||||||||||
| 2011-06-30 | $49.02K 10-Q · filed 2012-08-09 | $3.19M 10-Q · filed 2011-08-15 | ||||||||||||||
| 2010-12-31 | $19.91K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18 | $953.32K derived: sum of 2 quarters · filed 2013-03-18 | $2.33M 10-K · filed 2013-03-18 | |||||||||||||
| 2010-09-30 | $933.41K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-18 | $2.31M 10-Q/A · filed 2011-11-18 | ||||||||||||||
| 2010-06-30 | $1.37M 10-Q · filed 2011-08-15 | |||||||||||||||
| 2009-12-31 | $116.95K 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |